- Home
- JXG vs PYPD Comparison
JXG vs PYPD Comparison
Compare JXG & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JXG | PYPD |
|---|---|---|
| Founded | N/A | 2008 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.6M | 107.0M |
| IPO Year | 2012 | 2014 |
Fundamental Metrics
Financial Performance| Metric | JXG | PYPD |
|---|---|---|
| Price | $7.20 | $5.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $11.40 |
| AVG Volume (30 Days) | 33.3K | ★ 108.8K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $3.50 |
| 52 Week High | $12.00 | $5.84 |
Technical Indicators
Market Signals| Indicator | JXG | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 56.18 |
| Support Level | $6.11 | $4.18 |
| Resistance Level | $7.97 | $5.58 |
| Average True Range (ATR) | 0.71 | 0.28 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 54.49 | 68.29 |
Price Performance
Historical ComparisonAbout JXG JX Luxventure Limited
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products. The Company's operations are located in the PRC and all of the Company's revenue is derived from sales to customers in the PRC region.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.